These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 33243603)

  • 21. Anterior Gradient-2 monoclonal antibody inhibits lung cancer growth and metastasis by upregulating p53 pathway and without exerting any toxicological effects: A preclinical study.
    Negi H; Merugu SB; Mangukiya HB; Li Z; Zhou B; Sehar Q; Kamle S; Yunus FU; Mashausi DS; Wu Z; Li D
    Cancer Lett; 2019 May; 449():125-134. PubMed ID: 30685412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin 13 receptor alpha 2 (IL13Rα2): Expression, signaling pathways and therapeutic applications in cancer.
    Jaén M; Martín-Regalado Á; Bartolomé RA; Robles J; Casal JI
    Biochim Biophys Acta Rev Cancer; 2022 Sep; 1877(5):188802. PubMed ID: 36152905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor targeted delivery of doxorubicin in malignant peripheral nerve sheath tumors.
    Madhankumar AB; Mrowczynski OD; Slagle-Webb B; Ravi V; Bourcier AJ; Payne R; Harbaugh KS; Rizk E; Connor JR
    PLoS One; 2018; 13(1):e0181529. PubMed ID: 29304038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetic modulation enhances the therapeutic effect of anti-IL-13R(alpha)2 antibody in human mesothelioma xenografts.
    Takenouchi M; Hirai S; Sakuragi N; Yagita H; Hamada H; Kato K
    Clin Cancer Res; 2011 May; 17(9):2819-29. PubMed ID: 21357681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of tumor formation and metastasis by a monoclonal antibody against lymphatic vessel endothelial hyaluronan receptor 1.
    Hara Y; Torii R; Ueda S; Kurimoto E; Ueda E; Okura H; Tatano Y; Yagi H; Ohno Y; Tanaka T; Masuko K; Masuko T
    Cancer Sci; 2018 Oct; 109(10):3171-3182. PubMed ID: 30058195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-tax interacting protein-1 (TIP-1) monoclonal antibody targets human cancers.
    Yan H; Kapoor V; Nguyen K; Akers WJ; Li H; Scott J; Laforest R; Rogers B; Thotala D; Hallahan D
    Oncotarget; 2016 Jul; 7(28):43352-43362. PubMed ID: 27270318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting Interleukin-11 Receptor-α Impairs Human Endometrial Cancer Cell Proliferation and Invasion In Vitro and Reduces Tumor Growth and Metastasis In Vivo.
    Winship AL; Van Sinderen M; Donoghue J; Rainczuk K; Dimitriadis E
    Mol Cancer Ther; 2016 Apr; 15(4):720-30. PubMed ID: 26846819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel monoclonal antibody KMP1 has potential antitumor activity of bladder cancer by blocking CD44 in vivo and in vitro.
    Chen Y; Wang H; Zuo Y; Li N; Ding M; Li C
    Cancer Med; 2018 May; 7(5):2064-2077. PubMed ID: 29577645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional screen for secreted proteins by monoclonal antibody library and identification of Mac-2 Binding protein (Mac-2BP) as a potential therapeutic target and biomarker for lung cancer.
    Sun L; Chen L; Sun L; Pan J; Yu L; Han L; Yang Z; Luo Y; Ran Y
    Mol Cell Proteomics; 2013 Feb; 12(2):395-406. PubMed ID: 23184915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein- and DNA-based active immunotherapy targeting interleukin-13 receptor alpha2.
    Mintz A; Gibo DM; Madhankumar AB; Cladel NM; Christensen ND; Debinski W
    Cancer Biother Radiopharm; 2008 Oct; 23(5):581-9. PubMed ID: 18976118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of Liver Metastasis in Colorectal Cancer by Targeting IL-13/IL13Rα2 Binding Site with Specific Monoclonal Antibodies.
    Jaén M; Bartolomé RA; Aizpurua C; Martin-Regalado Á; Imbaud JI; Casal JI
    Cancers (Basel); 2021 Apr; 13(7):. PubMed ID: 33917458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LSR Antibody Therapy Inhibits Ovarian Epithelial Tumor Growth by Inhibiting Lipid Uptake.
    Hiramatsu K; Serada S; Enomoto T; Takahashi Y; Nakagawa S; Nojima S; Morimoto A; Matsuzaki S; Yokoyama T; Takahashi T; Fujimoto M; Takemori H; Ueda Y; Yoshino K; Morii E; Kimura T; Naka T
    Cancer Res; 2018 Jan; 78(2):516-527. PubMed ID: 29187404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Significance of interleukin-13 receptor alpha 2-targeted glioblastoma therapy.
    Thaci B; Brown CE; Binello E; Werbaneth K; Sampath P; Sengupta S
    Neuro Oncol; 2014 Oct; 16(10):1304-12. PubMed ID: 24723564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An-te-xiao capsule inhibits tumor growth in non-small cell lung cancer by targeting angiogenesis.
    Han L; Wang JN; Cao XQ; Sun CX; Du X
    Biomed Pharmacother; 2018 Dec; 108():941-951. PubMed ID: 30372906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An Anti-Cancer Peptide LVTX-8 Inhibits the Proliferation and Migration of Lung Tumor Cells by Regulating Causal Genes' Expression in p53-Related Pathways.
    Zhang P; Yan Y; Wang J; Dong X; Zhang G; Zeng Y; Liu Z
    Toxins (Basel); 2020 Jun; 12(6):. PubMed ID: 32498425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin-13 receptor alpha 2-targeted glioblastoma immunotherapy.
    Sengupta S; Thaci B; Crawford AC; Sampath P
    Biomed Res Int; 2014; 2014():952128. PubMed ID: 25247196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strongly enhanced antitumor activity of trastuzumab and pertuzumab combination treatment on HER2-positive human xenograft tumor models.
    Scheuer W; Friess T; Burtscher H; Bossenmaier B; Endl J; Hasmann M
    Cancer Res; 2009 Dec; 69(24):9330-6. PubMed ID: 19934333
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Engineered IL13 variants direct specificity of IL13Rα2-targeted CAR T cell therapy.
    Stern LA; Gholamin S; Moraga I; Yang X; Saravanakumar S; Cohen JR; Starr R; Aguilar B; Salvary V; Hibbard JC; Kalbasi A; Shepphird JK; O'Hearn J; Garcia KC; Brown CE
    Proc Natl Acad Sci U S A; 2022 Aug; 119(33):e2112006119. PubMed ID: 35939683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Schnurri-3 drives tumor growth and invasion in cancer cells expressing interleukin-13 receptor alpha 2.
    Bartolomé RA; Martín-Regalado Á; Pintado-Berninches L; Robles J; Ramírez-González MÁ; Boukich I; Sanchez-Gómez P; Balyasnikova IV; Casal JI
    Cell Death Dis; 2023 Nov; 14(11):742. PubMed ID: 37963919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monomethyl auristatin E-conjugated anti-EGFR antibody inhibits the growth of human EGFR-positive non-small cell lung cancer.
    Li Z; Wang M; Yu D; Luo W; Fang J; Huang C; Yao X
    Cancer Chemother Pharmacol; 2019 Jul; 84(1):61-72. PubMed ID: 31037333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.